| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RMD | ResMed Common Stock | Sale | $209,810 | -1,000 | -1.1% | $209.81 | 91,056 | 10 Jun 2024 | Direct | F1, F2 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The transaction was conducted under a Rule 10b5-1 plan adopted February 6, 2024. |
| F2 | Includes 94.177 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan. |